387 related articles for article (PubMed ID: 35416635)
1. Systemic Therapy in Metastatic Hepatocellular Carcinoma.
Elms D; Badami A; Dhanarajan A
Curr Gastroenterol Rep; 2022 May; 24(5):65-71. PubMed ID: 35416635
[TBL] [Abstract][Full Text] [Related]
2. Non-immunotherapy options for the first-line management of hepatocellular carcinoma: exploring the evolving role of sorafenib and lenvatinib in advanced disease.
Perera S; Kelly D; O'Kane GM
Curr Oncol; 2020 Nov; 27(Suppl 3):S165-S172. PubMed ID: 33343210
[TBL] [Abstract][Full Text] [Related]
3. Drug Treatment for Advanced Hepatocellular Carcinoma: First-Line and Beyond.
Feng MY; Chan LL; Chan SL
Curr Oncol; 2022 Aug; 29(8):5489-5507. PubMed ID: 36005172
[TBL] [Abstract][Full Text] [Related]
4. Immune-Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma: A Synopsis of Response Rates.
Shek D; Read SA; Nagrial A; Carlino MS; Gao B; George J; Ahlenstiel G
Oncologist; 2021 Jul; 26(7):e1216-e1225. PubMed ID: 33818870
[TBL] [Abstract][Full Text] [Related]
5. Systemic treatment for unresectable hepatocellular carcinoma.
Leowattana W; Leowattana T; Leowattana P
World J Gastroenterol; 2023 Mar; 29(10):1551-1568. PubMed ID: 36970588
[TBL] [Abstract][Full Text] [Related]
6. Lenvatinib: established and promising drug for the treatment of advanced hepatocellular carcinoma.
Catalano M; Casadei-Gardini A; Vannini G; Campani C; Marra F; Mini E; Roviello G
Expert Rev Clin Pharmacol; 2021 Nov; 14(11):1353-1365. PubMed ID: 34289756
[TBL] [Abstract][Full Text] [Related]
7. Systemic therapy for advanced hepatocellular carcinoma: targeted therapies.
Tella SH; Kommalapati A; Mahipal A
Chin Clin Oncol; 2021 Feb; 10(1):10. PubMed ID: 32434345
[TBL] [Abstract][Full Text] [Related]
8. Optimizing Survival and the Changing Landscape of Targeted Therapy for Intermediate and Advanced Hepatocellular Carcinoma: A Systematic Review.
Lim H; Ramjeesingh R; Liu D; Tam VC; Knox JJ; Card PB; Meyers BM
J Natl Cancer Inst; 2021 Feb; 113(2):123-136. PubMed ID: 32898239
[TBL] [Abstract][Full Text] [Related]
9. Advances in novel systemic therapies for advanced hepatocellular carcinoma.
Carloni R; Rizzo A; Cusmai A; Palloni A; Federico AD; Marco MD; Massafra R; Fanizzi A; Palmiotti G; Brandi G
Future Med Chem; 2022 Oct; 14(20):1455-1470. PubMed ID: 35997677
[TBL] [Abstract][Full Text] [Related]
10. Systemic targeted and immunotherapy for advanced hepatocellular carcinoma.
Cersosimo RJ
Am J Health Syst Pharm; 2021 Jan; 78(3):187-202. PubMed ID: 33211092
[TBL] [Abstract][Full Text] [Related]
11. Paradigm shift in the treatment options of hepatocellular carcinoma.
Su TH; Hsu SJ; Kao JH
Liver Int; 2022 Aug; 42(9):2067-2079. PubMed ID: 34515412
[TBL] [Abstract][Full Text] [Related]
12. Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline.
Gordan JD; Kennedy EB; Abou-Alfa GK; Beg MS; Brower ST; Gade TP; Goff L; Gupta S; Guy J; Harris WP; Iyer R; Jaiyesimi I; Jhawer M; Karippot A; Kaseb AO; Kelley RK; Knox JJ; Kortmansky J; Leaf A; Remak WM; Shroff RT; Sohal DPS; Taddei TH; Venepalli NK; Wilson A; Zhu AX; Rose MG
J Clin Oncol; 2020 Dec; 38(36):4317-4345. PubMed ID: 33197225
[TBL] [Abstract][Full Text] [Related]
13. Emerging drugs for the treatment of hepatocellular carcinoma.
Ayoub WS; Jones PD; Yang JD; Martin P
Expert Opin Emerg Drugs; 2022 Jun; 27(2):141-149. PubMed ID: 35642526
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular carcinoma, novel therapies on the horizon.
El Dika I; Makki I; Abou-Alfa GK
Chin Clin Oncol; 2021 Feb; 10(1):12. PubMed ID: 32527116
[TBL] [Abstract][Full Text] [Related]
15. TKIs in combination with immunotherapy for hepatocellular carcinoma.
Stefanini B; Ielasi L; Chen R; Abbati C; Tonnini M; Tovoli F; Granito A
Expert Rev Anticancer Ther; 2023 Mar; 23(3):279-291. PubMed ID: 36794716
[TBL] [Abstract][Full Text] [Related]
16. Role of immunotherapy in the management of hepatocellular carcinoma: current standards and future directions.
Weinmann A; Galle PR
Curr Oncol; 2020 Nov; 27(Suppl 3):S152-S164. PubMed ID: 33343209
[TBL] [Abstract][Full Text] [Related]
17. The Treatment Landscape of Advanced Hepatocellular Carcinoma.
Wong KM; King GG; Harris WP
Curr Oncol Rep; 2022 Jul; 24(7):917-927. PubMed ID: 35347594
[TBL] [Abstract][Full Text] [Related]
18. Management of hepatocellular carcinoma after progression on first-line systemic treatment: defining the optimal sequencing strategy in second line and beyond.
Amaro CP; Tam VC
Curr Oncol; 2020 Nov; 27(Suppl 3):S173-S180. PubMed ID: 33343211
[TBL] [Abstract][Full Text] [Related]
19. Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline Update.
Gordan JD; Kennedy EB; Abou-Alfa GK; Beal E; Finn RS; Gade TP; Goff L; Gupta S; Guy J; Hoang HT; Iyer R; Jaiyesimi I; Jhawer M; Karippot A; Kaseb AO; Kelley RK; Kortmansky J; Leaf A; Remak WM; Sohal DPS; Taddei TH; Wilson Woods A; Yarchoan M; Rose MG
J Clin Oncol; 2024 May; 42(15):1830-1850. PubMed ID: 38502889
[TBL] [Abstract][Full Text] [Related]
20. AGA Clinical Practice Guideline on Systemic Therapy for Hepatocellular Carcinoma.
Su GL; Altayar O; O'Shea R; Shah R; Estfan B; Wenzell C; Sultan S; Falck-Ytter Y
Gastroenterology; 2022 Mar; 162(3):920-934. PubMed ID: 35210014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
